药企整体招聘正迈向"小而精"：尽管药企整体招聘依旧未现明 显的复苏趋势，总体招聘量级仍有所缩减，但这并非代表药企 过去两年，在与药企管理者沟通过程中，科锐国际高级副总裁段立新发现，"寒冬"一词成为他们交流时高 频提及的关键词。药企管理者普遍感慨，企业的融资难度持续加大，叠加产品价格管控影响，企业利润空 间正快速收窄。 已有29年医药行业综合从业经验的段立新认为，现在市场环境更像是"新黄金时代的清晨"——药企已从疯 狂扩张转向"以质换量"，聚焦提升产品创新力和公司的高效管理。不过短期内，全球药企管理者仍能感受 到行业调整带来的一丝凉意。 段立新： 关键是药企的增长模式已经发生转变。过去，药企利润空间可观，资金储备充裕，因此有着强烈 的扩张意愿，倾向于通过广纳人才来扩大企业规模。然而，近两年来，随着药企面临产品价格管控和企业 融资难度等压力，企业整体招聘需求也随之持续萎缩。例如，此前一家大型医药公司动辄每年招聘1000— 2000名医药代表，但如今这样的现象已成为过去式。《调研报告》显示，多数药企的招聘总量尚未出现明 显回升：43%的企业表示本年度招聘量较上年持平，33%的受访药企表示本年度的招聘总量仍在下滑。此 ...

Joincare Pharmaceutical Group Industry Co., Ltd. Interim Report 2025 Joincare Pharmaceutical Group Industry Co., Ltd. Interim Report 2025 Important Notice Ⅰ The Board of Directors (the "Board"), the Board of Supervisors and directors, supervisors and senior management of the Company hereby warrant the truthfulness, accuracy and completeness of the contents of the interim report (the "Report"), and that there are no false representations, misleading statements or material omissions contained in the Report, a ...

Domestic Financial Market - The Shanghai Composite Index closed at 3639.67, with a slight increase of 0.16%, while the Shenzhen Component Index decreased by 0.18% to 11157.94 [3][8] - The trading volume in the Shanghai and Shenzhen markets reached 1.83 trillion, an increase of 914 billion compared to the previous trading day [8] Macro News Summary - Standard & Poor's maintained China's sovereign credit rating at "A+" with a stable outlook, which was acknowledged by the Ministry of Finance [5] - The General Administration of Customs reported a 3.5% year-on-year increase in China's goods trade import and export for the first seven months of the year, accelerating by 0.6 percentage points compared to the first half of the year [5] Industry Dynamics - The eSIM industry is experiencing explosive growth, reshaping the communication ecosystem, with related stocks including Unisoc (002049) and Cheng Tian Wei Ye (300689) [6] - High-end PCB supply and demand are tightening, leading to accelerated production expansion by listed companies, with related stocks including Dazhu Laser (002008) and Dongshan Precision (002384) [6] - Significant transactions are occurring in the AI pharmaceutical sector, attracting attention to high-growth concept stocks such as Tigermed (300347) and Mediso (688202) [6] Company Focus - Tower Group (002233) reported a 92.47% year-on-year increase in net profit for the first half of 2025 and plans to repurchase shares worth 50 million to 100 million [7] - BeiGene (688235) achieved a net profit of 450 million, turning a profit compared to the previous year, with projected revenue for 2025 between 35.8 billion and 38.1 billion RMB [7] - Tongyu Communication (002792) has successfully scaled MacroWiFi testing and commercial deployment in Southeast Asia, providing reliable outdoor digital communication infrastructure for operators and enterprises [7] - Zhongke Chuangda (300496) focuses on robotics products for factory and warehouse logistics, including various AMR and unmanned forklift products [7] Market Review and Outlook - The market showed a slight upward trend, with the Shanghai Composite Index reaching a new rebound high of 3645 points, although over 3000 stocks declined, indicating a relatively flat market sentiment [8][9] - Despite the overall rebound trend, there are signs of divergence within the market, suggesting a potential need for a digestion and repair process in the short term [8][9] - For conservative investors, it is recommended to continue holding positions and consider allocating to broad-based index ETFs or industry ETFs [9]

Group 1: Pharmaceutical Sector - Haisen Pharmaceutical has seen a 10.01% increase over two days, driven by raw material drug demand [2] - Zhongsheng Pharmaceutical debuted with a 10.02% rise, attributed to innovative drug developments [2] - Duori Pharmaceutical experienced a 20.00% surge, linked to cold medicine sales [2] - Yuheng Pharmaceutical's stock rose by 9.84% on its first board, related to the pharmaceutical sector [2] - New World reported an 18.13% increase, also in the cold medicine category [2] - Senxuan Pharmaceutical's stock increased by 15.07%, attributed to cold medicine [2] - Wuxi Jinghai's stock rose by 10.75%, driven by amino acid products [3] - Keyuan Pharmaceutical saw a 10.63% increase, linked to pharmaceutical and recombinant developments [3] Group 2: Chemical Sector - Suzhou Longjie has achieved a 10.03% increase over 11 days, driven by chemical fiber and military applications [5] - Yong'an Pharmaceutical's stock rose by 9.99% over 8 days, attributed to taurine products [5] - Huide Technology experienced a 10.00% increase over three days, linked to chemical products [5] - Yongguan New Materials debuted with a 10.00% rise, related to chemical applications [5] - Youfu Co. saw a 9.97% increase, attributed to chemical fiber and technology [5] - Yanggu Huatai's stock rose by 12.01%, linked to chemical and restructuring activities [6] Group 3: Robotics Sector - Zhongchao Holdings has achieved a 10.05% increase over 15 days, driven by robotics and nuclear power applications [8] - Xuelong Group debuted with a 9.98% rise, attributed to automotive and robotics [8] - Lanke Technology's stock rose by 9.99%, linked to chemical and robotics [8] - Wangcheng Technology experienced a significant 16.30% increase, driven by robotics [8] - Lanjian Intelligent's stock rose by 14.74%, also in the robotics sector [8] Group 4: Nuclear Power Sector - Shangwei Co. has seen a 10.03% increase over two days, driven by nuclear power and high-tech applications [11] - Rongfa Nuclear Power debuted with a 9.96% rise, linked to controllable nuclear fusion [11] - Xue Ren Co. experienced a 10.04% increase, attributed to controllable nuclear fusion [11] Group 5: Automotive Sector - BYD reported a 169% increase in electric vehicle registrations in April, surpassing Tesla for the first time [14] - Hanma Technology debuted with a 10.08% rise, linked to automotive applications [15] - Power New Technology's stock rose by 10.07%, attributed to automotive and engine developments [15] - Sailis saw a 10.00% increase, related to automotive manufacturing [15] Group 6: Solid-State Battery Sector - Binhai Energy achieved a 10.03% increase over five days, driven by solid-state battery developments [16] - Yinglian Co. debuted with a 10.02% rise, linked to solid-state battery technology [16]

| | | | | | | | 未計及[编纂] | 計及[编纂] | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 代價结算日期 | 所認購 | 本公司募集 | 本公司 | 影響的 | 影響後 | 校[编纂] | | 序蒙 | 輪次 | 殷份購買協議日期 | (最後付款) | 股份数量 | 资金额 | 投微值值 | 每股成本 | 的每股成本 | 的折讓(1) | | | | | | | (美元) | (美元) | (美元) | (差元) | | | 1 ... | A 给 (1) | 2018年6月1日 | 2018年6月12日 | 904,888 | 6.0日高 | 54.4 日 展 | 6.63 | 【消费】 | [编纂]% | | 2 ... | B (3) | 2019年8月12日 | 2019年9月4日 | 4,403,933 | 36.8日高 | 106.8自昌 | 8.35 | (通貨) | [瑞景] | | 3 ... | Cl =(1)(2) | 2021年6月16日 | 2021年7月6日 | ...